Compassionate use of Lenalidomide with Pioglitazone, Etoricoxib, Dexamethasone and low-dose Treosulfan: Combined anti-inflammatory, immunomodulatory and angiostatic treatment in patients (pts) with docetaxel-refractory, castration-resistant prostate cancer (CRPC)

Vogelhuber, M. and Andreesen, R. and Meidenbauer, N. and Reichle, A. (2011) Compassionate use of Lenalidomide with Pioglitazone, Etoricoxib, Dexamethasone and low-dose Treosulfan: Combined anti-inflammatory, immunomodulatory and angiostatic treatment in patients (pts) with docetaxel-refractory, castration-resistant prostate cancer (CRPC). ONKOLOGIE, 34 (Suppl6). p. 180. ISSN 0378-584X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 05 May 2020 05:43
Last Modified: 05 May 2020 05:43
URI: https://pred.uni-regensburg.de/id/eprint/20263

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.